| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 150, Issue 12 5484-5493, Copyright © 1993 by American Association of Immunologists
ARTICLES |
SL Epstein, JA Misplon, CM Lawson, EK Subbarao, M Connors and BR Murphy
Molecular Immunology Laboratory, Food and Drug Administration, Bethesda, MD 20892.
Immunity to viral infections includes both antibody and T cell components. The contributions of humoral and cell-mediated immune responses vary depending on virus and host factors. We have used an in vivo challenge system to examine protective immunity to influenza A(H1N1) virus infection in immunocompetent B6 (H-2b) mice, and in H-2b mice homozygous for disruption of the gene for beta 2-microglobulin, termed beta 2 mu(-/-) mice. The latter mice do not express conventional MHC class I complexes on cell surfaces and lack CD8+ class I-restricted T cells. Ten vaccinia virus recombinants, each expressing 1 of the 10 proteins of influenza virus, were used to immunize the mice. Normal mice were protected against challenge with influenza virus by vaccination with HA-VAC and NA-VAC, but not by any of the vaccinia vectors expressing one of the eight other influenza virus proteins nor by a mixture of all eight of the latter vectors. Similar results were observed in mice of H-2d or H-2k MHC haplotypes. The beta 2 mu(-/-) mice were also protected by immunization with HA-VAC and NA-VAC, demonstrating that classical CD8+ CTL responses were not required for protection. Depletion of CD4+ T cells in either normal or beta 2 mu(-/- ) mice at the time of challenge had little or no effect on protection induced by HA-VAC or NA-VAC, suggesting that preformed antibody is the dominant mediator of protective immunity induced by these recombinants. Antibody responses to vaccinia virus Ag and expressed influenza virus Ag were lower in titer in beta 2 mu(-/-) mice than in normal B6 mice, suggesting an influence of MHC class I complexes, CD8+ T cells, or their products on antibody production.
This article has been cited by other articles:
|
|
 |
|
  G. A. Oliveira, K. A. Kumar, J. M. Calvo-Calle, C. Othoro, D. Altszuler, V. Nussenzweig, and E. H. Nardin Class II-Restricted Protective Immunity Induced by Malaria Sporozoites Infect. Immun., March 1, 2008; 76(3): 1200 - 1206. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Webby, S. Andreansky, J. Stambas, J. E. Rehg, R. G. Webster, P. C. Doherty, and S. J. Turner Protection and compensation in the influenza virus-specific CD8+ T cell response PNAS, June 10, 2003; 100(12): 7235 - 7240. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. T. Belz, D. Wodarz, G. Diaz, M. A. Nowak, and P. C. Doherty Compromised Influenza Virus-Specific CD8+-T-Cell Memory in CD4+-T-Cell-Deficient Mice J. Virol., October 25, 2002; 76(23): 12388 - 12393. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Crowe Jr., C.-Y. Firestone, and B. R. Murphy Passively Acquired Antibodies Suppress Humoral But Not Cell-Mediated Immunity in Mice Immunized with Live Attenuated Respiratory Syncytial Virus Vaccines J. Immunol., October 1, 2001; 167(7): 3910 - 3918. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. M. Tumpey, M. Renshaw, J. D. Clements, and J. M. Katz Mucosal Delivery of Inactivated Influenza Vaccine Induces B-Cell-Dependent Heterosubtypic Cross-Protection against Lethal Influenza A H5N1 Virus Infection J. Virol., June 1, 2001; 75(11): 5141 - 5150. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. L. Epstein, A. Stack, J. A. Misplon, C.-Y. Lo, H. Mostowski, J. Bennink, and K. Subbarao Vaccination with DNA encoding internal proteins of influenza virus does not require CD8+ cytotoxic T lymphocytes: either CD4+ or CD8+ T cells can promote survival and recovery after challenge Int. Immunol., January 1, 2000; 12(1): 91 - 101. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Moskophidis and D. Kioussis Contribution of Virus-specific CD8+ Cytotoxic T Cells to Virus Clearance or Pathologic Manifestations of Influenza Virus Infection in a T Cell Receptor Transgenic Mouse Model J. Exp. Med., July 20, 1998; 188(2): 223 - 232. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. C. Su, L. P. Cousens, L. D. Fast, M. K. Slifka, R. D. Bungiro, R. Ahmed, and C. A. Biron CD4+ and CD8+ T Cell Interactions in IFN-{gamma} and IL-4 Responses to Viral Infections: Requirements for IL-2 J. Immunol., May 15, 1998; 160(10): 5007 - 5017. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Bot, S. Casares, S. Bot, H. von Boehmer, and C. Bona Cellular Mechanisms Involved in Protection Against Influenza Virus Infection in Transgenic Mice Expressing a TCR Receptor Specific for Class II Hemagglutinin Peptide in CD4+ and CD8+ T Cells J. Immunol., May 1, 1998; 160(9): 4500 - 4507. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. Epstein, C.-Y. Lo, J. A. Misplon, and J. R. Bennink Mechanism of Protective Immunity Against Influenza Virus Infection in Mice Without Antibodies J. Immunol., January 1, 1998; 160(1): 322 - 327. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
